NDAVAGINALCREAM
Approved
Sep 1945
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 22h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SULTRIN is a triple sulfonamide vaginal cream combining sulfabenzamide, sulfacetamide, and sulfathiazole, approved in 1945 for vaginal infections. It represents a fixed-combination antimicrobial approach to treating bacterial vaginosis and related vaginal conditions. The synergistic combination of three sulfa agents provides broad-spectrum coverage against common vaginal pathogens.
LOE Approaching
Product is in late-stage life cycle with approaching loss of exclusivity; commercial teams are likely focused on defensive positioning and portfolio transition planning rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
SULTRIN offers minimal career growth opportunity given its LOE-approaching status and zero linked job openings; roles tend to be defensive and administrative rather than strategically expanding. This is a product for specialists seeking experience in portfolio transition, lifecycle extension strategies, or regulatory expertise on legacy products.
Brand ManagerProduct Manager
Worked on SULTRIN at Johnson & Johnson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.